Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)

Drug
General health
Online since 16 April 2024, updated 285 days ago

About this trial

This study will be investigating the effects of fesoterodine on autonomic dysreflexia (AD) in patients with spinal cord injuries (SCI). The goal of the study is to examine the effect of increasing dai...

Included participants

Gender
All
Age
18 - 60 years
Injury level
C1 - T6
  • Severity (AIS)?
  • AIS-A
    AIS-B
    AIS-C
    AIS-D
    Time since injury
    1 year - 60 years
  • Injury type
  • Traumatic

    Healthy volunteers
    No
    C1-T6

    What’s involved

    Type

    Drug

    Details

    There are no details yet

    Potential benefits

    Main benefits

    General health

    Additional benefits

    Bladder health/function

    Mental health and psychosocial factors

    Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more

    • Trial recruitment status
    • Ended
    • Trial start date
    • 25 Feb 2016
    • Organisation
    • University of British Columbia
    • Trial recruitment status
    • Ended
    • Trial start date
    • 25 Feb 2016
    • Organisation
    • University of British Columbia

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more